nodes	percent_of_prediction	percent_of_DWPC	metapath
Thiabendazole—CYP1A2—Carmustine—malignant glioma	0.849	1	CbGbCtD
Thiabendazole—Lansoprazole—CYP2C18—malignant glioma	0.0136	1	CrCbGaD
Thiabendazole—Visual acuity reduced—Temozolomide—malignant glioma	0.00787	0.064	CcSEcCtD
Thiabendazole—Cholestasis—Temozolomide—malignant glioma	0.00616	0.0501	CcSEcCtD
Thiabendazole—Liver injury—Temozolomide—malignant glioma	0.00556	0.0453	CcSEcCtD
Thiabendazole—Coordination abnormal—Carmustine—malignant glioma	0.00493	0.0401	CcSEcCtD
Thiabendazole—Coordination abnormal—Temozolomide—malignant glioma	0.00477	0.0388	CcSEcCtD
Thiabendazole—Hepatic failure—Temozolomide—malignant glioma	0.00378	0.0308	CcSEcCtD
Thiabendazole—Hyperglycaemia—Carmustine—malignant glioma	0.00274	0.0223	CcSEcCtD
Thiabendazole—Hyperglycaemia—Temozolomide—malignant glioma	0.00265	0.0216	CcSEcCtD
Thiabendazole—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.0026	0.0211	CcSEcCtD
Thiabendazole—Hypoaesthesia—Carmustine—malignant glioma	0.00242	0.0197	CcSEcCtD
Thiabendazole—Visual impairment—Carmustine—malignant glioma	0.00234	0.0191	CcSEcCtD
Thiabendazole—Hypoaesthesia—Temozolomide—malignant glioma	0.00234	0.019	CcSEcCtD
Thiabendazole—Visual impairment—Temozolomide—malignant glioma	0.00227	0.0184	CcSEcCtD
Thiabendazole—Flushing—Carmustine—malignant glioma	0.00226	0.0184	CcSEcCtD
Thiabendazole—Erythema multiforme—Temozolomide—malignant glioma	0.00222	0.0181	CcSEcCtD
Thiabendazole—Tinnitus—Temozolomide—malignant glioma	0.00219	0.0178	CcSEcCtD
Thiabendazole—Flushing—Temozolomide—malignant glioma	0.00218	0.0177	CcSEcCtD
Thiabendazole—Chills—Temozolomide—malignant glioma	0.00211	0.0172	CcSEcCtD
Thiabendazole—Vision blurred—Carmustine—malignant glioma	0.002	0.0162	CcSEcCtD
Thiabendazole—Vision blurred—Temozolomide—malignant glioma	0.00193	0.0157	CcSEcCtD
Thiabendazole—Leukopenia—Carmustine—malignant glioma	0.0019	0.0154	CcSEcCtD
Thiabendazole—Angioedema—Temozolomide—malignant glioma	0.00187	0.0152	CcSEcCtD
Thiabendazole—Convulsion—Carmustine—malignant glioma	0.00183	0.0149	CcSEcCtD
Thiabendazole—Leukopenia—Temozolomide—malignant glioma	0.00183	0.0149	CcSEcCtD
Thiabendazole—Convulsion—Temozolomide—malignant glioma	0.00177	0.0144	CcSEcCtD
Thiabendazole—Confusional state—Carmustine—malignant glioma	0.00174	0.0142	CcSEcCtD
Thiabendazole—Confusional state—Temozolomide—malignant glioma	0.00168	0.0137	CcSEcCtD
Thiabendazole—Anaphylactic shock—Temozolomide—malignant glioma	0.00167	0.0136	CcSEcCtD
Thiabendazole—Anorexia—Carmustine—malignant glioma	0.00165	0.0134	CcSEcCtD
Thiabendazole—Hypotension—Carmustine—malignant glioma	0.00161	0.0131	CcSEcCtD
Thiabendazole—Anorexia—Temozolomide—malignant glioma	0.00159	0.013	CcSEcCtD
Thiabendazole—Somnolence—Carmustine—malignant glioma	0.00154	0.0125	CcSEcCtD
Thiabendazole—Decreased appetite—Carmustine—malignant glioma	0.0015	0.0122	CcSEcCtD
Thiabendazole—Somnolence—Temozolomide—malignant glioma	0.00148	0.0121	CcSEcCtD
Thiabendazole—Dyspepsia—Temozolomide—malignant glioma	0.00147	0.012	CcSEcCtD
Thiabendazole—Decreased appetite—Temozolomide—malignant glioma	0.00145	0.0118	CcSEcCtD
Thiabendazole—Fatigue—Temozolomide—malignant glioma	0.00144	0.0117	CcSEcCtD
Thiabendazole—Feeling abnormal—Carmustine—malignant glioma	0.00142	0.0116	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Carmustine—malignant glioma	0.00141	0.0115	CcSEcCtD
Thiabendazole—Feeling abnormal—Temozolomide—malignant glioma	0.00138	0.0112	CcSEcCtD
Thiabendazole—Abdominal pain—Carmustine—malignant glioma	0.00137	0.0111	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Temozolomide—malignant glioma	0.00137	0.0111	CcSEcCtD
Thiabendazole—Abdominal pain—Temozolomide—malignant glioma	0.00132	0.0107	CcSEcCtD
Thiabendazole—Hypersensitivity—Carmustine—malignant glioma	0.00127	0.0104	CcSEcCtD
Thiabendazole—Asthenia—Carmustine—malignant glioma	0.00124	0.0101	CcSEcCtD
Thiabendazole—Hypersensitivity—Temozolomide—malignant glioma	0.00123	0.01	CcSEcCtD
Thiabendazole—Asthenia—Temozolomide—malignant glioma	0.0012	0.00975	CcSEcCtD
Thiabendazole—Diarrhoea—Carmustine—malignant glioma	0.00118	0.00962	CcSEcCtD
Thiabendazole—Pruritus—Temozolomide—malignant glioma	0.00118	0.00961	CcSEcCtD
Thiabendazole—Dizziness—Carmustine—malignant glioma	0.00114	0.0093	CcSEcCtD
Thiabendazole—Diarrhoea—Temozolomide—malignant glioma	0.00114	0.0093	CcSEcCtD
Thiabendazole—Dizziness—Temozolomide—malignant glioma	0.0011	0.00898	CcSEcCtD
Thiabendazole—Vomiting—Carmustine—malignant glioma	0.0011	0.00894	CcSEcCtD
Thiabendazole—Rash—Carmustine—malignant glioma	0.00109	0.00886	CcSEcCtD
Thiabendazole—Dermatitis—Carmustine—malignant glioma	0.00109	0.00886	CcSEcCtD
Thiabendazole—Headache—Carmustine—malignant glioma	0.00108	0.00881	CcSEcCtD
Thiabendazole—Vomiting—Temozolomide—malignant glioma	0.00106	0.00864	CcSEcCtD
Thiabendazole—Rash—Temozolomide—malignant glioma	0.00105	0.00857	CcSEcCtD
Thiabendazole—Dermatitis—Temozolomide—malignant glioma	0.00105	0.00856	CcSEcCtD
Thiabendazole—Headache—Temozolomide—malignant glioma	0.00105	0.00851	CcSEcCtD
Thiabendazole—Nausea—Carmustine—malignant glioma	0.00103	0.00835	CcSEcCtD
Thiabendazole—Nausea—Temozolomide—malignant glioma	0.000992	0.00807	CcSEcCtD
Thiabendazole—CYP1A1—Oxidation by Cytochrome P450—POR—malignant glioma	0.000755	0.0524	CbGpPWpGaD
Thiabendazole—CYP1A1—Xenobiotics—CYP2B6—malignant glioma	0.000641	0.0445	CbGpPWpGaD
Thiabendazole—CYP1A1—Xenobiotics—CYP2C18—malignant glioma	0.000556	0.0386	CbGpPWpGaD
Thiabendazole—CYP1A2—Oxidation by Cytochrome P450—POR—malignant glioma	0.000482	0.0334	CbGpPWpGaD
Thiabendazole—CYP1A1—Tryptophan metabolism—ASMT—malignant glioma	0.000462	0.0321	CbGpPWpGaD
Thiabendazole—CYP1A2—Xenobiotics—CYP2B6—malignant glioma	0.000409	0.0284	CbGpPWpGaD
Thiabendazole—CYP1A2—Xenobiotics—CYP2C18—malignant glioma	0.000355	0.0246	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL12A—malignant glioma	0.00032	0.0223	CbGpPWpGaD
Thiabendazole—CYP1A2—Tryptophan metabolism—ASMT—malignant glioma	0.000295	0.0205	CbGpPWpGaD
Thiabendazole—CYP1A1—Tryptophan metabolism—CYP2C18—malignant glioma	0.000286	0.0198	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—NF1—malignant glioma	0.000286	0.0198	CbGpPWpGaD
Thiabendazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.000268	0.0186	CbGpPWpGaD
Thiabendazole—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.000266	0.0185	CbGpPWpGaD
Thiabendazole—CYP1A1—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.000263	0.0183	CbGpPWpGaD
Thiabendazole—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000231	0.016	CbGpPWpGaD
Thiabendazole—CYP1A1—Oxidative Stress—SOD1—malignant glioma	0.000231	0.016	CbGpPWpGaD
Thiabendazole—CYP1A1—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000228	0.0158	CbGpPWpGaD
Thiabendazole—CYP1A1—Oxidative Stress—CAT—malignant glioma	0.000219	0.0152	CbGpPWpGaD
Thiabendazole—CYP1A1—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000216	0.015	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12A—malignant glioma	0.000204	0.0142	CbGpPWpGaD
Thiabendazole—CYP1A1—Arachidonic acid metabolism—PTGS1—malignant glioma	0.000202	0.0141	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—malignant glioma	0.000201	0.014	CbGpPWpGaD
Thiabendazole—CYP1A1—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000187	0.013	CbGpPWpGaD
Thiabendazole—CYP1A2—Tryptophan metabolism—CYP2C18—malignant glioma	0.000182	0.0126	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—NF1—malignant glioma	0.000182	0.0126	CbGpPWpGaD
Thiabendazole—CYP1A1—Estrogen Receptor Pathway—STAT3—malignant glioma	0.000178	0.0123	CbGpPWpGaD
Thiabendazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.00017	0.0118	CbGpPWpGaD
Thiabendazole—CYP1A2—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.000168	0.0116	CbGpPWpGaD
Thiabendazole—CYP1A1—Tryptophan metabolism—CAT—malignant glioma	0.000156	0.0108	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—HES1—malignant glioma	0.000148	0.0103	CbGpPWpGaD
Thiabendazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000147	0.0102	CbGpPWpGaD
Thiabendazole—CYP1A2—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000145	0.0101	CbGpPWpGaD
Thiabendazole—CYP1A1—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000142	0.00985	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000138	0.00956	CbGpPWpGaD
Thiabendazole—CYP1A2—Arachidonic acid metabolism—PTGS1—malignant glioma	0.000129	0.00896	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—malignant glioma	0.000128	0.00891	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000119	0.00829	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—CYP2B6—malignant glioma	0.000115	0.00796	CbGpPWpGaD
Thiabendazole—CYP1A2—Estrogen Receptor Pathway—STAT3—malignant glioma	0.000113	0.00787	CbGpPWpGaD
Thiabendazole—CYP1A1—Metapathway biotransformation—CYP2B6—malignant glioma	0.000113	0.00785	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—CYP2C18—malignant glioma	9.94e-05	0.0069	CbGpPWpGaD
Thiabendazole—CYP1A2—Tryptophan metabolism—CAT—malignant glioma	9.93e-05	0.0069	CbGpPWpGaD
Thiabendazole—CYP1A1—Metapathway biotransformation—CYP2C18—malignant glioma	9.81e-05	0.00681	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—malignant glioma	9.44e-05	0.00655	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	9.05e-05	0.00628	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase II conjugation—GSTT1—malignant glioma	8.77e-05	0.00609	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—malignant glioma	8.65e-05	0.00601	CbGpPWpGaD
Thiabendazole—CYP1A1—Tryptophan metabolism—MDM2—malignant glioma	8.6e-05	0.00597	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—RAF1—malignant glioma	8.57e-05	0.00595	CbGpPWpGaD
Thiabendazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	8.56e-05	0.00595	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—malignant glioma	8.3e-05	0.00576	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—GSTT1—malignant glioma	8.04e-05	0.00558	CbGpPWpGaD
Thiabendazole—CYP1A1—Arachidonic acid metabolism—PTGS2—malignant glioma	7.76e-05	0.00539	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—malignant glioma	7.72e-05	0.00536	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—malignant glioma	7.69e-05	0.00534	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—PTGS1—malignant glioma	7.54e-05	0.00523	CbGpPWpGaD
Thiabendazole—CYP1A1—PPARA activates gene expression—NCOR1—malignant glioma	7.33e-05	0.00509	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—CYP2B6—malignant glioma	7.31e-05	0.00508	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—CYP2B6—malignant glioma	7.21e-05	0.00501	CbGpPWpGaD
Thiabendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—NCOR1—malignant glioma	7.17e-05	0.00498	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—malignant glioma	6.53e-05	0.00454	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—CYP2C18—malignant glioma	6.34e-05	0.0044	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—CYP2C18—malignant glioma	6.25e-05	0.00434	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase II conjugation—GSTP1—malignant glioma	6.08e-05	0.00422	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—MYC—malignant glioma	6.01e-05	0.00417	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—malignant glioma	5.88e-05	0.00408	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—malignant glioma	5.88e-05	0.00408	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—RTEL1—malignant glioma	5.64e-05	0.00391	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—malignant glioma	5.6e-05	0.00389	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—TNF—malignant glioma	5.6e-05	0.00389	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—GSTP1—malignant glioma	5.57e-05	0.00387	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—malignant glioma	5.56e-05	0.00386	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—malignant glioma	5.52e-05	0.00383	CbGpPWpGaD
Thiabendazole—CYP1A1—Metapathway biotransformation—GSTP1—malignant glioma	5.5e-05	0.00382	CbGpPWpGaD
Thiabendazole—CYP1A2—Tryptophan metabolism—MDM2—malignant glioma	5.49e-05	0.00381	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—malignant glioma	5.47e-05	0.0038	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—malignant glioma	5.29e-05	0.00367	CbGpPWpGaD
Thiabendazole—CYP1A1—PPARA activates gene expression—PPARG—malignant glioma	5.25e-05	0.00365	CbGpPWpGaD
Thiabendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—malignant glioma	5.14e-05	0.00357	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—GSTT1—malignant glioma	5.13e-05	0.00356	CbGpPWpGaD
Thiabendazole—CYP1A2—Arachidonic acid metabolism—PTGS2—malignant glioma	4.95e-05	0.00344	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—NCOR1—malignant glioma	4.94e-05	0.00343	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—malignant glioma	4.92e-05	0.00342	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—malignant glioma	4.9e-05	0.0034	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—PTGS1—malignant glioma	4.81e-05	0.00334	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—malignant glioma	4.17e-05	0.00289	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	4.03e-05	0.0028	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	3.9e-05	0.00271	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—MYC—malignant glioma	3.83e-05	0.00266	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—malignant glioma	3.75e-05	0.0026	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—malignant glioma	3.75e-05	0.0026	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—RTEL1—malignant glioma	3.59e-05	0.0025	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—malignant glioma	3.57e-05	0.00248	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—malignant glioma	3.57e-05	0.00248	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—GSTP1—malignant glioma	3.55e-05	0.00247	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—malignant glioma	3.54e-05	0.00246	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—malignant glioma	3.54e-05	0.00246	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—GSTP1—malignant glioma	3.51e-05	0.00243	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—COX8A—malignant glioma	3.24e-05	0.00225	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	2.89e-05	0.00201	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ASMT—malignant glioma	2.75e-05	0.00191	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	2.69e-05	0.00187	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—BCAN—malignant glioma	2.59e-05	0.0018	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	2.57e-05	0.00178	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	2.49e-05	0.00173	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—IDH2—malignant glioma	2.09e-05	0.00145	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—COX8A—malignant glioma	2.06e-05	0.00143	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.97e-05	0.00137	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CYP2B6—malignant glioma	1.96e-05	0.00136	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	1.85e-05	0.00128	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—IDH1—malignant glioma	1.79e-05	0.00125	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ASMT—malignant glioma	1.76e-05	0.00122	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—SPHK1—malignant glioma	1.74e-05	0.00121	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	1.72e-05	0.00119	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CYP2C18—malignant glioma	1.7e-05	0.00118	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—BCAN—malignant glioma	1.65e-05	0.00115	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.6e-05	0.00111	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.46e-05	0.00101	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.41e-05	0.000979	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GSTT1—malignant glioma	1.38e-05	0.000955	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—IDH2—malignant glioma	1.33e-05	0.000924	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PTGS1—malignant glioma	1.29e-05	0.000895	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.28e-05	0.000892	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.25e-05	0.000871	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CYP2B6—malignant glioma	1.25e-05	0.000868	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—BCHE—malignant glioma	1.2e-05	0.000832	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—SLC5A5—malignant glioma	1.18e-05	0.000822	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—IDH1—malignant glioma	1.14e-05	0.000794	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.12e-05	0.000777	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.11e-05	0.00077	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—SPHK1—malignant glioma	1.11e-05	0.000769	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CYP2C18—malignant glioma	1.08e-05	0.000753	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.02e-05	0.00071	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	9.67e-06	0.000672	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GSTP1—malignant glioma	9.53e-06	0.000662	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	9.31e-06	0.000647	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CAT—malignant glioma	9.28e-06	0.000644	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	8.99e-06	0.000624	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GSTT1—malignant glioma	8.77e-06	0.000609	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—NCOR1—malignant glioma	8.76e-06	0.000608	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PTGS1—malignant glioma	8.22e-06	0.000571	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	8.19e-06	0.000569	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—BCHE—malignant glioma	7.64e-06	0.00053	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—SLC5A5—malignant glioma	7.55e-06	0.000524	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CAV1—malignant glioma	7.14e-06	0.000496	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	7.14e-06	0.000496	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	7.07e-06	0.000491	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	6.82e-06	0.000474	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PIK3CG—malignant glioma	6.51e-06	0.000452	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PPARG—malignant glioma	6.28e-06	0.000436	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	6.17e-06	0.000428	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GSTP1—malignant glioma	6.08e-06	0.000422	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CAT—malignant glioma	5.92e-06	0.000411	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PIK3CD—malignant glioma	5.72e-06	0.000397	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—NCOR1—malignant glioma	5.59e-06	0.000388	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PIK3CB—malignant glioma	4.98e-06	0.000346	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PTGS2—malignant glioma	4.94e-06	0.000343	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CAV1—malignant glioma	4.55e-06	0.000316	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.35e-06	0.000302	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PTEN—malignant glioma	4.31e-06	0.000299	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PIK3CG—malignant glioma	4.15e-06	0.000288	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PPARG—malignant glioma	4e-06	0.000278	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PIK3CD—malignant glioma	3.65e-06	0.000253	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PIK3CB—malignant glioma	3.18e-06	0.000221	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PTGS2—malignant glioma	3.15e-06	0.000219	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PIK3CA—malignant glioma	3.04e-06	0.000211	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PTEN—malignant glioma	2.75e-06	0.000191	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—AKT1—malignant glioma	2.48e-06	0.000172	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PIK3CA—malignant glioma	1.94e-06	0.000135	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—AKT1—malignant glioma	1.58e-06	0.00011	CbGpPWpGaD
